These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3497884)

  • 21. Requirements for triggering of lysis by cytolytic T lymphocyte clones.
    Lancki DW; Weiss A; Fitch FW
    J Immunol; 1987 Jun; 138(11):3646-53. PubMed ID: 2953785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.
    Staerz UD; Bevan MJ
    Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1453-7. PubMed ID: 2869486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clustered CD3/TCR complexes do not transduce activation signals after bispecific monoclonal antibody-triggered lysis by cytotoxic T lymphocytes via CD3.
    Blank-Voorthuis CJ; Braakman E; Ronteltap CP; Tilly BC; Sturm E; Warnaar SO; Bolhuis RL
    J Immunol; 1993 Sep; 151(6):2904-14. PubMed ID: 8376761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective binding of concanavalin A to target cell major histocompatibility antigens is required to induce nonspecific conjugation and lysis by cytolytic T lymphocytes in lectin-dependent cytotoxicity.
    Keren Z; Berke G
    Cell Immunol; 1984 Dec; 89(2):458-77. PubMed ID: 6334564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition of interspecies hybrid class I histocompatibility antigens by antigen-specific cytolytic T lymphocytes.
    Maziarz R; Allen H; Strominger JL; Flavell R; Biro PA; Burakoff SJ
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6276-80. PubMed ID: 3875858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bispecific antibodies reactive with the multidrug-resistance-related glycoprotein and CD3 induce lysis of multidrug-resistant tumor cells.
    Van Dijk J; Tsuruo T; Segal DM; Bolhuis RL; Colognola R; van de Griend RJ; Fleuren GJ; Warnaar SO
    Int J Cancer; 1989 Oct; 44(4):738-43. PubMed ID: 2793246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of DNA-mediated gene transfer to analyze the role of H-2Ld in controlling the specificity of anti-vesicular stomatitis virus cytotoxic T cells.
    Forman J; Goodenow RS; Hood L; Ciavarra R
    J Exp Med; 1983 Apr; 157(4):1261-72. PubMed ID: 6187888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Participation of a dominant cytotoxic T cell population defined by a monoclonal antibody in syngeneic anti-tumor responses.
    Matsubayashi Y; Hirama T; Morioka A; Iwashiro M; Masuda T; Uchino H; Takeshita S; Yamagishi H; Udono H; Mieno M
    Eur J Immunol; 1990 Sep; 20(9):2095-103. PubMed ID: 1698639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis.
    Kranz DM; Patrick TA; Brigle KE; Spinella MJ; Roy EJ
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9057-61. PubMed ID: 7568072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: the pattern of in vitro reactivity predicts the in vivo effect on different tumours.
    Rodolfo M; Bassi C; Salvi C; Parmiani G
    Cancer Immunol Immunother; 1991; 34(1):53-62. PubMed ID: 1760812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of monoclonal antibodies specific for the T cell receptor complex by Fc receptor-mediated CTL lysis.
    Leo O; Sachs DH; Samelson LE; Foo M; Quinones R; Gress R; Bluestone JA
    J Immunol; 1986 Dec; 137(12):3874-80. PubMed ID: 3097135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies specific for H-2K and H-2D antigens on cytotoxic T cells can inhibit their function.
    O'Neill HC
    Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1443-7. PubMed ID: 3006052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between CD8 dependency and determinant density using peptide-induced, Ld-restricted cytotoxic T lymphocytes.
    Alexander MA; Damico CA; Wieties KM; Hansen TH; Connolly JM
    J Exp Med; 1991 Apr; 173(4):849-58. PubMed ID: 1901079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B; López D; López de Castro JA
    J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli.
    Gruber M; Schodin BA; Wilson ER; Kranz DM
    J Immunol; 1994 Jun; 152(11):5368-74. PubMed ID: 8189055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes.
    Ferrini S; Sforzini S; Cambiaggi A; Poggi A; Meazza R; Canevari S; Colnaghi MI; Moretta L
    Int J Cancer; 1994 Mar; 56(6):846-52. PubMed ID: 7907079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. I. Significant bispecific lysis of syngeneic colon carcinoma CC531 is critically dependent on prolonged preactivation of effector T-lymphocytes by immobilized anti-T-cell receptor antibody.
    Beun GD; van Eendenburg DH; Corver WE; van de Velde CJ; Fleuren GJ
    J Immunother (1991); 1992 May; 11(4):238-48. PubMed ID: 1599909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.